2019-nCOV situation: 7 Feb 2020
To view images in this newsletter, please allow images and html options.
Pandemic Threats and Health Emergencies
2019-nCOV situation: 7 Feb 2020
Welcome to this special issue of the newsletter where we highlight latest research and policy news and literature on 2019-nCVO situation
Please send your feedback, articles and reports, or questions you would like to share to Dr. Chadia Wannous via email firstname.lastname@example.org
Wishing you useful reading!
WHO situation report no 17
- No new countries reported cases of 2019-nCoV in the past 24 hours.
- WHO is working with partnersto strengthenglobal diagnostic capacity for 2019-nCoV detection to improve surveillance and track the spread of disease.WHO and partners have activated a network of specialized referral laboratories with demonstrated expertise in the molecular detection of coronaviruses. These international labs can support national labs to confirm new cases and troubleshoot their molecular assays.
- WHO is convening a global research and innovation forum to mobilize international action in response to the new coronavirus,covering a broad spectrum of research areas including epidemiology, clinical care, vaccines, therapeutics, diagnostics, animal health, social sciences, and other topics.More details can be found here
- WHO RISK ASSESSMENT
China Very High
Regional Level High
Global Level High
Novel coronavirus (2019-nCoV) situation as of 07 February 2020, 10:00 (CET)
China’s National Health Commission Feb 7: Daily briefing on novel coronavirus cases in China
On Feb 6, 31 provincial-level regions on the Chinese mainland as well as the Xinjiang Production and Construction Corps reported 3,143 new cases of confirmed infections (including 2,447 in Hubei province), 4,833 new cases of suspected infections (including 2,622 in Hubei province), 962 new serious cases (including 918 in Hubei province), and 73 deaths (69 in Hubei province, 1 in Jilin province, 1 in Henan province, 1 in Guangdong province and 1 in Hainan province). 387 patients were released from hospitals after being cured, including 184 in Hubei province. 26,762 people who had had close contact with infected patients were freed from medical observation.
WHO to accelerate research and innovation for new coronavirus
WHO will convene a “global research and innovation forum” to facilitate advanced research and development on topics to include vaccines and therapeutic products. The meeting will be held February 11-12 in Geneva, Switzerland
International Reference Laboratories
In its February 6 Situation Report, the WHO announced 15 reference laboratories have been designated to support the 2019-nCoV response. The list includes 1 laboratory each in the US, UK, Russia, Australia, and China as well as 5 more in Asia, 3 in Europe, and 2 in Africa.
Leishenshan Hospital gets ready for novel coronavirus patients
The second emergency specialty field hospital built in Wuhan, Hubei province, to combat the novel coronavirus outbreak, is scheduled to start treating patients on Feb 6
Virus-hit Wuhan speeds up diagnosis, treatment of patients
Orderly production resumption is underway in anti-epidemic battles
China to improve diagnostic efficiency of novel coronavirus pneumonia
Wuhan's second SARS treatment-model hospital starts delivery
Beijing to complete renovation of SARS treatment hospital in mid-February
‘We need everyone for this’: U.S. hospitals harnessing resources to brace for any spike in coronavirus cases
Shipping of CDC 2019 Novel Coronavirus Diagnostic Test Kits Begins
Distribution of CDC Diagnostic Test Kits Will Expand Laboratory Capacity to Detect 2019-nCoV
'A contaminated prison': Scared, angry passengers are trapped on three cruise ships amid coronavirus outbreak
Cruise ship that visited Hong Kong searches for a port after Philippines, Japan deny entry
Updates on Diamond Princess
The Diamond Princess—currently quarantined in Yokohama, Japan—has reported that 41 additional passengers tested positive.
Passengers on cruise ship docked near New York City will be assessed for coronavirus, CDC official says
Scientific publications and reports and news
Scientists question work suggesting pangolin coronavirus link
What happens next in the coronavirus outbreak? We mapped 8 scenarios.
Four ways it could devolve into a dangerous pandemic, and four ways it could steadily improve.
Peak coronavirus? Epidemic forecasts are often wrong but can be useful
How to Prepare for a Coronavirus Pandemic
The Worst-Case Scenario Isn’t Inevitable, but It Can’t Be Ignored
How Hong Kong Beat SARS: Lessons Learned
Hand‐Hygiene Mitigation Strategies Against Global Disease Spreading through the Air Transportation Network
Study: To slow an epidemic, focus on handwashing
Improving the rate of handwashing at just 10 major airports could significantly slow the spread of a viral disease, researchers estimate. And the greater the improvement in people’s handwashing habits at airports, the more dramatic the effect on slowing the disease, the researchers found.
20 Seconds to Optimize Hand Wellness
One of the world’s most crucial and selfless acts is still simply washing your hands.
WHO Technical guidance
- Surveillance and case definitions
- Laboratory guidance
- Clinical management for suspected novel coronavirus
- Home care for patients with suspected novel coronavirus
- Infection prevention and control
- Risk communications
- Readiness checklist
- Disease commodity package
- Reducing transmission from animals to humans
- Early investigations
WHO Critical Care Severe Acute Respiratory Infection Training
This course is intended for clinicians who are working in intensive care units (ICUs) in low and middle-income countries and managing adult and pediatric patients with severe forms of acute respiratory infection (SARI), including severe pneumonia, acute respiratory distress syndrome (ARDS), sepsis and septic shock. It is a hands-on practical guide to be used by health care professionals involved in critical care management during outbreaks of influenza virus (seasonal) human infection due avian influenza virus (H5N1, H7N9), MERS-CoV, nCoV or other emerging respiratory viral epidemics.
Thank you for reading. If you have thoughts, feedback, story ideas, or questions you would like to share or interested in partnering with us on a special event coverage, please send a note to Chadia Wannous via email@example.com